Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takero Shindo

Showing results (51-60 of 63) with videos related to

Pageof 7
Sort By:
Frontiers in Immunology|March 21, 2022
Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow TransplantationMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Cell Reports. Medicine|May 31, 2025
Cross-organ hierarchy of HLA molecular mismatches in donor-specific antibody development in solid organ transplantationsMasaaki Hirata, Kazuto Tsukita, Takero Shindo, et al.
Annals of Hematology|November 27, 2019
Clinical impact of the CONUT score in patients with multiple myelomaSho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, et al.
Ejhaem|July 30, 2025
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short ReportTomomi Oka, Takeshi Nakajima, Makoto Iwasaki, et al.
International Journal of Hematology|June 5, 2020
The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapseSaiko Kurosawa, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.
Cell Stem Cell|August 20, 2025
Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's diseaseAsuka Morizane, Emi Yamasaki, Takero Shindo, et al.
HLA|June 18, 2024
Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphomaSatoko Morishima, Makoto Yoshimitsu, Takero Shindo, et al.
Nature|April 16, 2025
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's diseaseNobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Blood Neoplasia|June 2, 2025
KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational studyHiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, et al.
Pageof 7

Showing results (51-60 of 63) with videos related to

Sort By:
Pageof 7
Frontiers in Immunology|March 21, 2022
Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow TransplantationMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Cell Reports. Medicine|May 31, 2025
Cross-organ hierarchy of HLA molecular mismatches in donor-specific antibody development in solid organ transplantationsMasaaki Hirata, Kazuto Tsukita, Takero Shindo, et al.
Annals of Hematology|November 27, 2019
Clinical impact of the CONUT score in patients with multiple myelomaSho Okamoto, Hiroshi Ureshino, Keisuke Kidoguchi, et al.
Ejhaem|July 30, 2025
The Intersection of Lynch Syndrome and Hematological Malignancies: A Rare Short ReportTomomi Oka, Takeshi Nakajima, Makoto Iwasaki, et al.
International Journal of Hematology|June 5, 2020
The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapseSaiko Kurosawa, Hiroki Yamaguchi, Takuhiro Yamaguchi, et al.
Cell Stem Cell|August 20, 2025
Control of immune response in an iPSC-based allogeneic cell therapy clinical trial for Parkinson's diseaseAsuka Morizane, Emi Yamasaki, Takero Shindo, et al.
HLA|June 18, 2024
Individual HLAs affect survival after allogeneic stem cell transplantation in adult T-cell leukaemia/lymphomaSatoko Morishima, Makoto Yoshimitsu, Takero Shindo, et al.
Nature|April 16, 2025
Phase I/II trial of iPS-cell-derived dopaminergic cells for Parkinson's diseaseNobukatsu Sawamoto, Daisuke Doi, Etsuro Nakanishi, et al.
Transplantation|February 14, 2025
Impact of HLA Epitope Matching on Outcomes in Haploidentical HSCT With Distinct GVHD ProphylaxesMakoto Iwasaki, Junya Kanda, Hidenori Tanaka, et al.
Blood Neoplasia|June 2, 2025
KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational studyHiroshi Ureshino, Yasunori Ueda, Shin Fujisawa, et al.
Pageof 7